mlsanityData to 14 Oct 2026

PMO-Dock: Benchmarking Docking, Specificity, and Generalization in Molecular Optimization

arXiv 2610.19011 ↗First posted 13 Oct 2026cs.LG q-bio.QMcited by 0

Not on the map. Why?

Abstract (arXiv)

The Practical Molecular Optimization (PMO) benchmark standardized evaluation in molecular optimization, but it is built on simple property-based oracles that do not capture structure-based drug design. As the field has moved to docking-based objectives, evaluation practice has become unstandardized, and different methods report results on different docking tasks, often without a shared protocol for fair comparison or sample-efficiency constraints. To address this, we introduce Practical Molecular Optimization for Docking (PMO-Dock), a benchmark and protocol for docking-based optimization consisting of 25 tasks covering hit generation, lead optimization, and a new specificity task requiring strong on-target binding while penalizing off-target interactions. The protocol separates model development from final evaluation: validation tasks are used for hyperparameter tuning, and test tasks are held out for final evaluation and are not used during development. Evaluation on the test tasks is done under a strict oracle budget to reflect realistic drug-discovery settings. We benchmark four diverse high-performing methods spanning different optimization paradigms, Saturn (reinforcement learning), GenMol (discrete diffusion), Genetic-guided GFlowNet, and ChemLlama (LLM-based evolutionary search). Our results show no universally best method across tasks, additional analyses of hyperparameter transfer (cross-task and cross-category) and sensitivity show that transfer is often limited and varies by method, motivating method-dependent selection strategies. This benchmark provides a concrete standard for evaluating generalization to unseen tasks and sample efficiency under a limited test-time oracle budget.

Key facts. No citing papers in the map yet (data through 14 Oct 2026). Builds on 11 of its 21 references that are in the map. First posted on arXiv 13 Oct 2026.

Builds on

11 of 21 references.

References · 11

  1. 2021Flow Network based Generative Models for Non-Iterative Diverse Candidate Generationcited by 392
  2. 2022Sample Efficiency Matters: A Benchmark for Practical Molecular Optimizationcited by 155
  3. 2024Efficient Evolutionary Search Over Chemical Space with Large Language Modelscited by 61
  4. 2025GenMol: A Drug Discovery Generalist with Discrete Diffusioncited by 50
  5. 2023Gotta be SAFE: A New Framework for Molecular Designcited by 48
  6. 2024Genetic-guided GFlowNets for Sample Efficient Molecular Optimizationcited by 39
  7. 2022Tartarus: A Benchmarking Platform for Realistic And Practical Inverse Molecular Designcited by 17
  8. 2024Saturn: Sample-efficient Generative Molecular Design using Memory Manipulationcited by 15
  9. 2020We Should at Least Be Able to Design Molecules That Dock Wellcited by 9
  10. 2023Beam Enumeration: Probabilistic Explainability For Sample Efficient Self-conditioned Molecular Designcited by 6
  11. 2024Small Molecule Optimization with Large Language Modelscited by 6

Built on by

Not cited yet.

Similar, not cited

Close in wording, no citation either way

  1. 2024Deep Confident Steps to New Pockets: Strategies for Docking Generalization
  2. 2022DiffDock: Diffusion Steps, Twists, and Turns for Molecular Docking
  3. 2026Beyond Affinity: A Benchmark of 1D, 2D, and 3D Methods Reveals Critical Trade-offs in Structure-Based Drug Design
  4. 2023DockGame: Cooperative Games for Multimeric Rigid Protein Docking
  5. 2026SEISMO: Explanation-Aware, Trajectory-Conditioned LLM Agents for Sample-Efficient Molecular Optimisation
  6. 2026SMDD-Bench: Can LLMs Solve Real-World Small Molecule Drug Design Tasks?
  7. 2024Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?
  8. 2025DrugImproverGPT: A Large Language Model for Drug Optimization with Fine-Tuning via Structured Policy Optimization